AI-generated summary
This randomized controlled trial in 40 patients with classical trigeminal neuralgia compared carbamazepine alone with carbamazepine plus 810 nm low-level laser therapy. The authors report that the combined group had significantly greater reduction in pain scores at 3 weeks and lower McGill scores at 3 months, and no dose escalation was needed in that group. The study was single-center and conducted in one Indian population.
- Participants
- 40
- Who or what was studied
- Patients with classical trigeminal neuralgia at a single tertiary care centre in India
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The abstract describes a single-center trial in one population and does not report long-term follow-up beyond 3 months or the blinding and allocation details beyond a blinded assessor.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Power
- 200 mW
- Total energy
- 6 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial, Low-level laser therapy, Photobiomodulation, Laser, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.